Completed

Phase 3
Age: 35Years - 68Years
All Genders
NCT00000553

HDL-Atherosclerosis Treatment Study (HATS)

Led by University of Washington · Updated on 2016-02-10

N/A

Participants Needed

N/A

Research Sites

335 weeks

Total Duration

On this page

Sponsors

U

University of Washington

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.

CONDITIONS

Official Title

HDL-Atherosclerosis Treatment Study (HATS)

Who Can Participate

Age: 35Years - 68Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Men and women with low HDL cholesterol, with at least one 50% stenotic coronary lesion or three 30% stenotic coronary lesions. Women range in age from 35 to less than 68 and men from 35 to less than 63.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

PREVENTION

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here